Stay updated on Magrolimab Combo in Untreated MDS: Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.

Latest updates to the Magrolimab Combo in Untreated MDS: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%
- Check17 days agoChange DetectedAdded revision tag v3.1.0 and removed several drug-safety subsections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); versioning indicates a content update with potential consolidation of drug-safety topics.SummaryDifference0.2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed; no other substantive changes detected.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new facility name and location details, as well as a comprehensive list of publications related to a specific clinical study. Notably, the drug azacitidine has been retained in the context of myelodysplastic syndromes, while previous location details have been removed.SummaryDifference6%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Magrolimab Combo in Untreated MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.